Bacteria make us feel pain... and suppress our immune response

Methicillin-resistant Staphylococcus aureus (green) forms an invasive bolus in subcutaneous tissue following infection that forms direct contact with sensory nerve fibers (red). Formyl peptides and pore-forming toxins produced by these bacteria directly activate firing at the nerve terminals, leading to pain sensations. Credit: Balthasar Heesters and Isaac Chiu

The pain of invasive skin infections caused by methicillin-resistant Staphylococcus aureus, and possibly other serious, painful infections, appear to be induced by the invading bacteria themselves, and not by the body's immune response as previously thought, report scientists at Boston Children's Hospital. What's more, their research demonstrates that once the pain neurons "sense" the bacteria, they suppress the immune system, potentially helping the bacteria become more virulent.

The study, conducted in a and published online by the journal Nature on August 21, could change the way doctors think about a variety of invasive, painful infections, such as meningitis, necrotizing fasciitis, , and .

"If we could block pain in infected tissues and also block what pain do to the , it could help us treat bacterial infections better," says Isaac Chiu, PhD, the study's first author and a neuro- in the laboratory of Clifford Woolf, PhD, at Boston Children's F.M. Kirby Neurobiology Program.

The study was launched after Chiu and coauthor Christian A. Von Hehn, MD, PhD, were culturing and together in a dish to see how they interact during an infection. "Surprisingly, the neurons were responding immediately to the ," says Chiu.

That inspired them to move to a live model of skin infection, the first one to their knowledge ever used to study pain, working closely with Balthasar Heesters, a graduate student in the lab of Michael Carroll, PhD, in the Program in Cellular and Molecular Medicine at Boston Children's.

The finding that pain neurons, once activated by bacteria, suppress the immune system was equally unexpected. "I was thinking they would do the opposite," says Chiu.

Why would the activated pain neurons try to weaken the immune response to infection? Chiu hypothesizes that the neurons are trying protect tissues from further damage caused by an inflammatory immune response—a protective mechanism that bacteria might be exploiting to their advantage.

In the study, Chiu and colleagues examined pain, tissue swelling, immune cell numbers and the number of live bacteria in mice with staphylococcal . They found that pain levels tracked closely with the number of live bacteria and peaked well before tissue swelling peaked, in keeping with bacteria being the cause of the pain and not a local inflammatory response. The team also documented communication between bacteria, pain neurons and key cells from the immune system.

Methicillin-resistant Staphylococcus aureus (green) forms an invasive bolus in subcutaneous tissue following infection that forms direct contact with sensory nerve fibers (white). Formyl peptides and pore-forming toxins produced by these bacteria directly activate firing at the nerve terminals, leading to pain sensations. Credit: Balthasar Heesters and Isaac Chiu

Bacteria "talk to neurons"

The research showed that S. aureus bacteria secrete two kinds of compounds that communicate with sensory neurons, inducing pain:

  • N-formyl peptides: Pain neurons carry receptors to detect these peptides, known as FPR1 receptors, the team demonstrated. When mice are unable to make these receptors, they show a reduced pain response.
  • Pore-forming toxins: These proteins, also secreted by other virulent bacteria, dock on the sensory nerve terminals and create large pores that let ions into the cells—triggering them to fire off pain messages. A pore-forming toxin known as alpha toxin is known to help S. aureus spread in the skin and lungs.

These findings suggest possible new approaches for blocking pain signaling by blocking the FPR1 receptor, blocking the receptor for alpha-toxin (ADAM10) on sensory neurons or possibly delivering a drug through the pores. These approaches also might prevent the neurons from suppressing the immune response, Chiu says, but this has yet to be proven.

Suppressing the immune system

Further experiments in mice demonstrated two ways in which the activated sensory neurons suppress the immune response at the local infection site, potentially allowing bacteria to proliferate:

  • Innate immunity: Activated pain-sensing neurons reduce the influx of neutrophils and monocytes, key first responders to infection. In mice, when these neurons were eliminated through genetic techniques, numbers of these immune cells increased. The team further showed that the neurons talk to the immune cells via peptide molecules. One called CGRP, for example, prevented macrophages from producing TNF-alpha, a critical signal that rallies further immune defenses against bacteria.
  • Draining lymph nodes: Normally, antigens from invading bacteria drain from the infection site to the lymph nodes, where T-cells and B-cells congregate and generate the body's second-wave . The team showed, however, that activated pain-sensing neurons reduce migration of T- and B-cells to the lymph nodes. In infected mice whose pain-sensing neurons were eliminated, the lymph nodes contained more of these cells.

The researchers plan to explore the pain-bacteria-immune system relationship further, and investigate treatments to block the pain caused by virulent bacterial infections, and perhaps to counter the immune suppression.

"We found that major parts of the immune system are not necessary for pain during infection, but that bacteria themselves are the source of much of the pain," summarizes Chiu. "In treating pain during infection, we may need to think about how to block the pathogenic components themselves, and not just the immune/inflammatory pathways. We also found that sensory neurons modulate the immune system after they're activated. This suggests, though we haven't yet been able to prove it, that the ability of virulent bacteria strains to cause may give them an advantage, by allowing them to use the neurons to suppress immunity."

More information: Nature paper: dx.doi.org/10.1038/nature12479

Related Stories

Putting the brakes on pain

Aug 05, 2013

Neuropathic pain—pain that results from a malfunction in the nervous system—is a daily reality for millions of Americans. Unlike normal pain, it doesn't go away after the stimulus that provoked it ends, and it also behaves ...

Some brain cells are better virus fighters

Mar 07, 2013

(Medical Xpress)—Viruses often spread through the brain in patchwork patterns, infecting some cells but missing others. New research at Washington University School of Medicine in St. Louis helps explain ...

Bacterial toxins cause deadly heart disease

Aug 20, 2013

University of Iowa researchers have discovered what causes the lethal effects of staphylococcal infective endocarditis - a serious bacterial infection of heart valves that kills approximately 20,000 Americans each year.

Recommended for you

Student seeks to improve pneumonia vaccines

14 hours ago

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

16 hours ago

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

Better living through mitochondrial derived vesicles

Aug 19, 2014

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

Aug 19, 2014

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

User comments